MX2020008925A - Composicion oftalmica que comprende dicuafosol y polimero cationico. - Google Patents
Composicion oftalmica que comprende dicuafosol y polimero cationico.Info
- Publication number
- MX2020008925A MX2020008925A MX2020008925A MX2020008925A MX2020008925A MX 2020008925 A MX2020008925 A MX 2020008925A MX 2020008925 A MX2020008925 A MX 2020008925A MX 2020008925 A MX2020008925 A MX 2020008925A MX 2020008925 A MX2020008925 A MX 2020008925A
- Authority
- MX
- Mexico
- Prior art keywords
- cationic
- copolymers
- hydrolyzed
- diquafosol
- cationic polymer
- Prior art date
Links
- 229920006317 cationic polymer Polymers 0.000 title abstract 3
- NMLMACJWHPHKGR-NCOIDOBVSA-N P(1),P(4)-bis(uridin-5'-yl) tetraphosphate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@H]2O)O)COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N2C(NC(=O)C=C2)=O)O)O)C=CC(=O)NC1=O NMLMACJWHPHKGR-NCOIDOBVSA-N 0.000 title abstract 2
- 229950003529 diquafosol Drugs 0.000 title abstract 2
- 125000002091 cationic group Chemical group 0.000 abstract 8
- 229920001577 copolymer Polymers 0.000 abstract 5
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 abstract 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract 2
- 229920001661 Chitosan Polymers 0.000 abstract 2
- 235000011037 adipic acid Nutrition 0.000 abstract 2
- 239000001361 adipic acid Substances 0.000 abstract 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 abstract 1
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 239000004593 Epoxy Substances 0.000 abstract 1
- 102000011782 Keratins Human genes 0.000 abstract 1
- 108010076876 Keratins Proteins 0.000 abstract 1
- 108010073771 Soybean Proteins Proteins 0.000 abstract 1
- 229920006322 acrylamide copolymer Polymers 0.000 abstract 1
- 235000019270 ammonium chloride Nutrition 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
- 235000021240 caseins Nutrition 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 125000004386 diacrylate group Chemical group 0.000 abstract 1
- -1 diallyl quaternary ammonium salt Chemical class 0.000 abstract 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229920001519 homopolymer Polymers 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920005573 silicon-containing polymer Polymers 0.000 abstract 1
- 235000019710 soybean protein Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Se proporciona una composición oftálmica que comprende dicuafosol o una sal del mismo y un polímero catiónico, siendo el polímero catiónico al menos uno seleccionado del grupo que consiste de quitosan, un derivado de quitosan, un copolímero de (met)acrilato catiónico, un polímero de silicona catiónica, un copolímero de sal de amonio cuaternario de dialiloacrilamida, queratina hidrolizada catiónica, seda hidrolizada catiónica, colágeno hidrolizado catiónico, caseína hidrolizada catiónica, proteína de soja hidrolizada catiónica, un copolímero de vinilpirrolidona catiónica, polivinilpirrolidona, un homopolímero de cloruro de dimetildiacrilamonio, un copolímero de ácido adípico-dimetilaminoh idroxipropildietilentriamina, un copolímero de ácido adípico-epoxipropildietilentriamina y un copolímero de sulfato de acrilamida-?-metacriloiloxietiltrimetil-amoniometilo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018035578 | 2018-02-28 | ||
| PCT/JP2019/007542 WO2019168023A1 (ja) | 2018-02-28 | 2019-02-27 | ジクアホソルおよびカチオン性ポリマーを含有する眼科用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020008925A true MX2020008925A (es) | 2020-10-01 |
Family
ID=67806273
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020008925A MX2020008925A (es) | 2018-02-28 | 2019-02-27 | Composicion oftalmica que comprende dicuafosol y polimero cationico. |
| MX2022014791A MX2022014791A (es) | 2018-02-28 | 2020-08-26 | Composicion oftalmica que comprende dicuafosol y polimero cationico. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022014791A MX2022014791A (es) | 2018-02-28 | 2020-08-26 | Composicion oftalmica que comprende dicuafosol y polimero cationico. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210000844A1 (es) |
| EP (1) | EP3760207A4 (es) |
| JP (4) | JP6716800B2 (es) |
| KR (2) | KR20220163519A (es) |
| CN (2) | CN117137866A (es) |
| BR (1) | BR112020017661A2 (es) |
| CA (1) | CA3091700A1 (es) |
| EA (1) | EA202092030A1 (es) |
| MX (2) | MX2020008925A (es) |
| PH (1) | PH12020551313A1 (es) |
| SG (1) | SG11202007977RA (es) |
| TW (2) | TWI781296B (es) |
| WO (1) | WO2019168023A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220163519A (ko) | 2018-02-28 | 2022-12-09 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 및 양이온성 폴리머를 함유하는 안과용 조성물 |
| WO2020175525A1 (ja) * | 2019-02-27 | 2020-09-03 | 参天製薬株式会社 | ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物 |
| KR20240049646A (ko) * | 2019-08-27 | 2024-04-16 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물 |
| JP7230169B2 (ja) * | 2020-12-25 | 2023-02-28 | 参天製薬株式会社 | ジクアホソルまたはその塩、銀塩およびイオン性等張化剤を含有する水性点眼液 |
| CN113712910A (zh) * | 2021-08-05 | 2021-11-30 | 广州市桐晖药业有限公司 | 一种滴眼液及其制备方法 |
| KR20230143117A (ko) | 2022-04-04 | 2023-10-11 | 서울대학교산학협력단 | 감미 억제용 조성물 및 식품의 감미 억제 방법 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01294620A (ja) | 1988-05-19 | 1989-11-28 | Kissei Pharmaceut Co Ltd | 水溶液製剤およびその製造方法 |
| US5358706A (en) * | 1992-09-30 | 1994-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| JP3155689B2 (ja) * | 1995-08-10 | 2001-04-16 | 昭和薬品化工株式会社 | 消炎点眼剤 |
| US5900407A (en) | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
| PT1012154E (pt) | 1997-07-25 | 2004-08-31 | Inspire Pharmaceuticals Inc | Sais de di(5'-tetrafosfato de uridina), metodo para a sua preparacao, e suas utilizacoes |
| KR100832821B1 (ko) * | 2000-05-30 | 2008-05-28 | 산텐 세이야꾸 가부시키가이샤 | 각막 상피 신장 촉진제 |
| SG177132A1 (en) * | 2005-02-14 | 2012-01-30 | Johnson & Johnson Vision Care | A comfortable ophthalmic device and methods of its production |
| JP4515960B2 (ja) | 2005-05-19 | 2010-08-04 | 株式会社資生堂 | 整髪料洗浄剤及びその使用方法 |
| KR100870104B1 (ko) * | 2005-11-28 | 2008-11-26 | 주식회사 머젠스 | 안구건조증 치료 및 예방용 조성물 |
| JP5421272B2 (ja) * | 2007-10-12 | 2014-02-19 | リゾルヴィクス・ファーマシューティカルズ・インコーポレイテッド | 眼病治療のための組成物及び方法 |
| US20110003816A1 (en) * | 2008-03-07 | 2011-01-06 | Sun Pharma Advanced Research Company Limited | Ophthalmic composition |
| SG10201508591UA (en) * | 2010-12-28 | 2015-11-27 | Santen Pharmaceutical Co Ltd | Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
| MX353874B (es) * | 2012-03-26 | 2018-02-01 | Santen Pharmaceutical Co Ltd | Gotas para los ojos que contienen diquafosol. |
| WO2015169728A1 (en) * | 2014-05-07 | 2015-11-12 | Croma-Pharma Gesellschaft M.B.H. | Aqueous ophthalmic solution and method for treating dry eye syndrome |
| CN106456791B (zh) * | 2014-06-10 | 2021-08-10 | 日本乐敦制药株式会社 | 眼科用水性组合物 |
| SG11201705138QA (en) * | 2014-12-25 | 2017-07-28 | Santen Pharmaceutical Co Ltd | Aqueous ophthalmic solution |
| KR101587385B1 (ko) | 2015-07-29 | 2016-01-21 | 국제약품공업주식회사 | 사이클로스포린 함유 무자극성의 안약조성물 및 편리한 제조방법 |
| TW201722419A (zh) * | 2015-08-24 | 2017-07-01 | 參天製藥股份有限公司 | 眼科用膜製劑 |
| JP6192130B2 (ja) | 2015-12-09 | 2017-09-06 | 株式会社大一商会 | 遊技機 |
| EP3266446B1 (en) * | 2016-07-07 | 2018-11-21 | Laboratorios SALVAT, S.A. | Ophthalmic composition comprising castor oil and medium chain triglyceride |
| CN106772747B (zh) * | 2016-12-26 | 2022-10-18 | 深圳市光科全息技术有限公司 | 一种光学膜及其制作方法 |
| JP6582029B2 (ja) * | 2017-10-03 | 2019-09-25 | 株式会社メニコン | 眼科用組成液及びその使用方法 |
| KR20220163519A (ko) | 2018-02-28 | 2022-12-09 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 및 양이온성 폴리머를 함유하는 안과용 조성물 |
| CN108853016A (zh) * | 2018-09-26 | 2018-11-23 | 广州大光制药有限公司 | 一种地夸磷索钠滴眼液及其制备方法 |
| WO2020175525A1 (ja) * | 2019-02-27 | 2020-09-03 | 参天製薬株式会社 | ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物 |
-
2019
- 2019-02-27 KR KR1020227041383A patent/KR20220163519A/ko active Search and Examination
- 2019-02-27 EA EA202092030A patent/EA202092030A1/ru unknown
- 2019-02-27 SG SG11202007977RA patent/SG11202007977RA/en unknown
- 2019-02-27 US US16/976,504 patent/US20210000844A1/en active Pending
- 2019-02-27 JP JP2020503563A patent/JP6716800B2/ja active Active
- 2019-02-27 TW TW108106730A patent/TWI781296B/zh active
- 2019-02-27 CN CN202311151214.4A patent/CN117137866A/zh active Pending
- 2019-02-27 CN CN201980015357.8A patent/CN111757742B/zh active Active
- 2019-02-27 EP EP19759990.5A patent/EP3760207A4/en active Pending
- 2019-02-27 BR BR112020017661-3A patent/BR112020017661A2/pt unknown
- 2019-02-27 KR KR1020207027473A patent/KR102472773B1/ko active IP Right Grant
- 2019-02-27 MX MX2020008925A patent/MX2020008925A/es unknown
- 2019-02-27 TW TW111140996A patent/TWI833406B/zh active
- 2019-02-27 CA CA3091700A patent/CA3091700A1/en active Pending
- 2019-02-27 WO PCT/JP2019/007542 patent/WO2019168023A1/ja unknown
-
2020
- 2020-06-10 JP JP2020100953A patent/JP7297718B2/ja active Active
- 2020-08-24 PH PH12020551313A patent/PH12020551313A1/en unknown
- 2020-08-26 MX MX2022014791A patent/MX2022014791A/es unknown
-
2022
- 2022-07-21 JP JP2022116528A patent/JP7472202B2/ja active Active
-
2024
- 2024-02-13 JP JP2024019332A patent/JP2024045506A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210000844A1 (en) | 2021-01-07 |
| TWI781296B (zh) | 2022-10-21 |
| PH12020551313A1 (en) | 2021-09-06 |
| SG11202007977RA (en) | 2020-09-29 |
| CA3091700A1 (en) | 2019-09-06 |
| KR20220163519A (ko) | 2022-12-09 |
| EA202092030A1 (ru) | 2020-11-16 |
| MX2022014791A (es) | 2023-01-16 |
| BR112020017661A2 (pt) | 2020-12-22 |
| EP3760207A4 (en) | 2023-10-04 |
| CN111757742A (zh) | 2020-10-09 |
| JP6716800B2 (ja) | 2020-07-01 |
| KR20200127002A (ko) | 2020-11-09 |
| JP7472202B2 (ja) | 2024-04-22 |
| KR102472773B1 (ko) | 2022-11-30 |
| CN111757742B (zh) | 2023-09-26 |
| EP3760207A1 (en) | 2021-01-06 |
| TWI833406B (zh) | 2024-02-21 |
| TW202306572A (zh) | 2023-02-16 |
| CN117137866A (zh) | 2023-12-01 |
| WO2019168023A1 (ja) | 2019-09-06 |
| JP2022136152A (ja) | 2022-09-15 |
| JP2024045506A (ja) | 2024-04-02 |
| JP7297718B2 (ja) | 2023-06-26 |
| TW202000212A (zh) | 2020-01-01 |
| JP2020138980A (ja) | 2020-09-03 |
| JPWO2019168023A1 (ja) | 2020-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022014791A (es) | Composicion oftalmica que comprende dicuafosol y polimero cationico. | |
| BR0114561A (pt) | Derivados amida reticulados do acido hialurÈnico e método de produção dos mesmos | |
| MA50746A (fr) | Protéines de fusion comprenant des enzymes d'enzymothérapie substitutive | |
| CL2018002825A1 (es) | Vacuna contra vrs | |
| WO2021125069A8 (en) | Composition comprising hyaluronic acid-based polyion complex particle | |
| EP3721816A3 (en) | Improved tissue fixation devices | |
| MXPA02012601A (es) | Polimeros radicales cationicos o anfotericos autoadhesivos y su uso en cosmeticos. | |
| RU2014109981A (ru) | Способ и устройство для инкапсулирования жесткой вставки в контактную линзу с целью коррекции астигматизма у пациентов | |
| WO2016113550A3 (en) | Dressing | |
| BR112018004455A2 (pt) | composição formadora de película | |
| SG11201810727SA (en) | Elastomer | |
| ATE452611T1 (de) | Geräte zur veränderung der relativen krümmung des felds und der positionen von peripheren achsenverschobenen fokalpositionen | |
| BRPI0109443B1 (pt) | hidrogel de silicone umectÁvel, lentes oftÁlmicas e mÉtodo de preparaÇço de um hidrogel de silicone. | |
| SG10201705219QA (en) | Preparation of N,N-(di)alkylaminoalkyl(meth)acrylamide or N,N-(di)alkylaminoalkyl (meth)acrylate and the quaternary ammonium salts thereof as flocculating aids and gelling agents | |
| EP2996172A3 (en) | Biocompatibility of biomedical energization elements | |
| EP3441049A3 (en) | Ophthalmic treatment device, system, and method of use | |
| BR112017018491A2 (pt) | hidrolisados de proteína à base de leite e composições produzidas a partir dos mesmos | |
| WO2017223261A3 (en) | Hydrogels, articles comprising hydrogels, and methods thereof | |
| EP3943076A3 (en) | A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders | |
| BR112015015813A2 (pt) | método e aparelho para ajustar a qualidade de vídeo com base em ambiente de rede | |
| MX353032B (es) | Sistema y método para programar una lente oftálmica energizada. | |
| WO2004069888A3 (en) | Block copolymers | |
| KR20120099621A (ko) | 연결 장치 | |
| MA49616A (fr) | Mutations de protéine d'enveloppe du vih stabilisant la forme trimère | |
| EP3958601A3 (en) | Handover method, device, and system |